David R Epstein Evelo Biosciences, Inc. (EVLO) insider trading activity

EVLO Quotes by TradingView

David R Epstein is Director of Evelo Biosciences, Inc.. Currently has a direct ownership of 93,932 shares of EVLO, which is worth approximately $0. The most recent transaction as insider was on Jun 30, 2022, when has been sold 4,927 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 93.9K
0% 3M change
0% 12M change
Total Value Held $0

David R Epstein Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 30 2022
BUY
Exercise of conversion of derivative security
-
4,927 Added 4.98%
93,932 Common Stock
May 31 2022
BUY
Exercise of conversion of derivative security
-
4,925 Added 5.24%
89,005 Common Stock
May 27 2022
BUY
Open market or private purchase
$25,000 $1.46 p/Share
17,123 Added 16.92%
84,080 Common Stock
May 02 2022
BUY
Exercise of conversion of derivative security
-
4,926 Added 6.85%
66,957 Common Stock
Mar 31 2022
BUY
Exercise of conversion of derivative security
-
4,926 Added 7.36%
62,031 Common Stock
Feb 28 2022
BUY
Exercise of conversion of derivative security
-
4,926 Added 7.94%
57,105 Common Stock
Jan 31 2022
BUY
Exercise of conversion of derivative security
-
4,925 Added 8.62%
52,179 Common Stock
Dec 31 2021
BUY
Exercise of conversion of derivative security
-
4,926 Added 9.44%
47,254 Common Stock
Nov 30 2021
BUY
Exercise of conversion of derivative security
-
4,926 Added 10.42%
42,328 Common Stock
Nov 01 2021
BUY
Exercise of conversion of derivative security
-
4,925 Added 11.64%
37,402 Common Stock
Oct 01 2021
BUY
Exercise of conversion of derivative security
-
4,927 Added 13.17%
32,477 Common Stock
Sep 03 2021
BUY
Exercise of conversion of derivative security
-
9,850 Added 26.34%
27,550 Common Stock
Dec 11 2020
BUY
Open market or private purchase
$52,129 $6.77 p/Share
7,700 Added 30.31%
17,700 Common Stock

Also insider at

IFF
INTERNATIONAL FLAVORS & FRAGRANCES INC Basic Materials
Director
RUBY
Rubius Therapeutics, Inc. Healthcare
Director
AXLA
Axcella Health Inc. Healthcare
Director
SNTI
Senti Biosciences, Inc. Healthcare
Director
SGEN
Seagen Inc. Healthcare
CEO
TEM
Tempus AI, Inc.
DRE

David R Epstein

Director
South San Francisco, CA

Track Institutional and Insider Activities on EVLO

Follow Evelo Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EVLO shares.

Notify only if

Insider Trading

Get notified when an Evelo Biosciences, Inc. insider buys or sells EVLO shares.

Notify only if

News

Receive news related to Evelo Biosciences, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EVLO